2Seventy Bio Inc (TSVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 10,684 | 12,034 | 36,048 | 41,621 | 56,177 |
| Cost of Goods | 3,147 | 4,959 | 4,517 | 4,295 | 4,493 |
| Gross Profit | 7,537 | 7,075 | 31,531 | 37,326 | 51,684 |
| Operating Expenses | 67,620 | 86,002 | 80,039 | 89,334 | 79,389 |
| Operating Income | -59,936 | -77,968 | -47,991 | -51,713 | -27,212 |
| Other Income | 3,114 | 6,330 | 5,902 | 4,692 | 4,069 |
| Pre-tax Income | -56,822 | -71,638 | -42,089 | -47,021 | -23,143 |
| Net Income Continuous | -56,822 | -71,638 | -42,089 | -47,021 | -23,143 |
| Net Income | $-56,822 | $-71,638 | $-42,089 | $-47,021 | $-23,143 |
| EPS Basic Total Ops | -1.11 | -1.40 | -0.83 | -1.08 | -0.15 |
| EPS Basic Continuous Ops | -1.11 | -1.40 | -0.83 | -1.08 | -0.15 |
| EPS Diluted Total Ops | -1.11 | -1.40 | -0.83 | -1.08 | -0.15 |
| EPS Diluted Continuous Ops | -1.11 | -1.40 | -0.83 | -1.08 | -0.15 |
| EPS Diluted Before Non-Recurring Items | -1.11 | -1.00 | -0.83 | N/A | N/A |
| EBITDA(a) | $-56,906 | $-63,150 | $-45,753 | $-49,458 | $-24,887 |